Posted by Clinical Lab Products | Sep 25, 2009 | Miscellaneous |
Proven Diagnostics announces that the companies have entered into a collaborative agreement. Through this collaboration, Proven Diagnostics will offer selected tests from ViraCor-IBTs menu of allergy, immunology and specialized infectious disease tests to its customers.
Read MorePosted by Clinical Lab Products | Sep 25, 2009 | Cancer, Miscellaneous |
Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that its BREVAGen breast cancer risk stratification test is now clinically available in select US markets.
Read MorePosted by Clinical Lab Products | Sep 16, 2009 | Miscellaneous |
VitaPath Genetics, a molecular diagnostics company, announced that it has closed a $6 million series A round of funding led by MDV-Mohr Davidow Ventures.
Read MorePosted by Clinical Lab Products | Sep 15, 2009 | Cancer, Miscellaneous |
Complete Genomics Inc, a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009
Read MorePosted by Clinical Lab Products | Sep 10, 2009 | Miscellaneous |
Adeona Pharmaceuticals Inc announces the initial formation of its sales and marketing team and pre-launch efforts for its CopperProof serum-based copper/zinc diagnostic panel, which will be offered through Adeona’s Hartlab subsidary.
Read More